SensDx is a biotechnology company that develops new diagnostic technology

Mobi SensDx

Mobi SensDx is the base for SensDx's technology. It is a multi-purpose diagnostic platform.

Flu SensDx

This product was launched in Poland in the autumn of 2019, and is already used at 100 doctors' offices and hospitals in the country.

SARS-CoV-2 test

The first internal evaluation of the SARS-CoV-2 test was performed on 100 positive and 500 negative samples with 92% sensitivity and 98.5% specificity.

Products under development

It is continuously researched and developed with the expansion of the product portfolio. Here are some products we have under development.